Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-13
1993-09-21
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514314, 546 14, 546153, 546156, C07D21520, C07D215233, A61K 3147
Patent
active
052469441
ABSTRACT:
Substituted quinolines and azaquinolines (1,5-naphthridines) attached through an oxymethylene bridge to novel substituted phenyl derivatives of the Formula I, are useful as angiotensin II antagonists. ##STR1##
REFERENCES:
patent: 5177095 (1993-01-01), Greenlee et al.
patent: 5183810 (1993-02-01), Greenlee et al.
Chemical Abstracts, vol. 86, No. 21, AB#155541b (1977).
Chakravarty Prasun K.
Greenlee William J.
Camara Valerie J.
DiPrima Joseph F.
Merck & Co. , Inc.
Rotman Alan L.
LandOfFree
Quinoline angiotensin II antagonists incorporating a substituted does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline angiotensin II antagonists incorporating a substituted, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline angiotensin II antagonists incorporating a substituted will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1050024